<SEC-DOCUMENT>0001737287-21-000010-index.html : 20210225
<SEC-HEADER>0001737287-21-000010.hdr.sgml : 20210225
<ACCEPTANCE-DATETIME>20210225170215
ACCESSION NUMBER:		0001737287-21-000010
CONFORMED SUBMISSION TYPE:	S-8
PUBLIC DOCUMENT COUNT:		4
REFERENCES 429:			333-227965
REFERENCES 429:			333-230164
REFERENCES 429:			333-236701
FILED AS OF DATE:		20210225
DATE AS OF CHANGE:		20210225
EFFECTIVENESS DATE:		20210225

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Allogene Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001737287
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				823562771
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-8
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-253530
		FILM NUMBER:		21681419

	BUSINESS ADDRESS:	
		STREET 1:		210 EAST GRAND AVENUE
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080
		BUSINESS PHONE:		(650) 457-2700

	MAIL ADDRESS:	
		STREET 1:		210 EAST GRAND AVENUE
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-8
<SEQUENCE>1
<FILENAME>allogene-formsx8x20210225.htm
<DESCRIPTION>S-8
<TEXT>
Document 1 - file: allogene-formsx8x20210225.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>2
<FILENAME>exhibit231-formsx8x20210225.htm
<DESCRIPTION>EX-23.1
<TEXT>
Document 2 - file: exhibit231-formsx8x20210225.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>3
<FILENAME>exhibit51-formsx8x20210225.htm
<DESCRIPTION>EX-5.1
<TEXT>
Document 3 - file: exhibit51-formsx8x20210225.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>cooley1.jpg
<TEXT>
Document 4 - file: cooley1.jpg

</DOCUMENT>
</SEC-DOCUMENT>